Validity of the Foot and Ankle Ability Measure in Athletes with Chronic Ankle Instability
Overview
Affiliations
Context: The Foot and Ankle Ability Measure (FAAM) is a region-specific, non-disease-specific outcome instrument that possesses many of the clinimetric qualities recommended for an outcome instrument. Evidence of validity to support the use of the FAAM is available in individuals with a wide array of ankle and foot disorders. However, additional evidence to support the use of the FAAM for those with chronic ankle instability (CAI) is needed.
Objective: To provide evidence of construct validity for the FAAM based on hypothesis testing in athletes with CAI.
Design: Between-groups comparison.
Setting: Athletic training room.
Patients Or Other Participants: Thirty National Collegiate Athletic Association Division II athletes (16 men, 14 women) from one university.
Main Outcome Measure(s): The FAAM including activities of daily living (ADL) and sports subscales and the global and categorical ratings of function.
Results: For both the ADL and sports subscales, FAAM scores were greater in healthy participants (100 +/- 0.0 and 99 +/- 3.5, respectively) than in subjects with CAI (88 +/- 7.7 and 76 +/- 12.7, respectively; P < .001). Similarly, for both ADL and sports subscales, FAAM scores were greater in athletes who indicated that their ankles were normal (98 +/- 6.3 and 96 +/- 6.9, respectively) than in those who classified their ankles as either nearly normal or abnormal (87 +/- 6.6 and 71 +/- 11.1, respectively; P < .001). We found relationships between FAAM scores and self-reported global ratings of function for both ADL and sports subscales. Relationships were stronger when all athletes, rather than just those with CAI, were included in the analyses.
Conclusions: The FAAM may be used to detect self-reported functional deficits related to CAI.
Piri M, Malmir K, Otadi K, Shadmehr A BMC Sports Sci Med Rehabil. 2025; 17(1):16.
PMID: 39885584 PMC: 11784114. DOI: 10.1186/s13102-025-01064-y.
Gao H, Chen X, Ren J, Zhang X, Hu Y, Ma Z PLoS One. 2025; 20(1):e0318535.
PMID: 39883688 PMC: 11781713. DOI: 10.1371/journal.pone.0318535.
Gungor E, Ercan N, Ovali S, Aydugan M, Cetin H Ulus Travma Acil Cerrahi Derg. 2024; 30(12):900-906.
PMID: 39668533 PMC: 11849883. DOI: 10.14744/tjtes.2024.20094.
Gupta J, Rizvi M, Sharma A, Sami W, Fahad A Al-Kuwari N, Hegazy F Heliyon. 2024; 10(23):e40484.
PMID: 39654717 PMC: 11626724. DOI: 10.1016/j.heliyon.2024.e40484.
Chia C, Fu S, He X, Cheng Y, Franco-Obregon A, Hua Y Trials. 2024; 25(1):808.
PMID: 39627831 PMC: 11613907. DOI: 10.1186/s13063-024-08639-z.